Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by ILF2 is the 45 kDa component of nuclear factor of activated T-cells (NFAT), a heterodimer of 45 kDa and 90 kDa proteins. Additionally we are shipping ILF2 Proteins (13) and ILF2 Kits (4) and many more products for this protein.
Showing 10 out of 95 products:
Human Polyclonal ILF2 Primary Antibody for WB - ABIN1881458
Karmakar, Mahajan, Schulz, Boyapaty, Weissman: A multiprotein complex necessary for both transcription and DNA replication at the β-globin locus. in The EMBO journal 2010
Show all 5 Pubmed References
Human Polyclonal ILF2 Primary Antibody for IHC, ELISA - ABIN190786
Wang, Rao, Chu, Shen, Levasseur, Theunissen, Orkin: A protein interaction network for pluripotency of embryonic stem cells. in Nature 2006
Show all 3 Pubmed References
Cow (Bovine) Polyclonal ILF2 Primary Antibody for IHC, WB - ABIN2776419
Shin, Kim, Cho, Lee, Rho: Host cell proteins binding to the encapsidation signal epsilon in hepatitis B virus RNA. in Archives of virology 2002
Show all 3 Pubmed References
Human Polyclonal ILF2 Primary Antibody for IF, IHC (p) - ABIN517145
Klinke, Kulkarni, Wu, Byrne-Hoffman: Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models. in Biotechnology and bioengineering 2014
Human Monoclonal ILF2 Primary Antibody for ELISA, WB - ABIN561481
Wang, Pandey, Hart: Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. in Molecular & cellular proteomics : MCP 2007
ILF2 interacts with RNA-binding proteins involved in the DNA damage response.
The data suggest that features of both the N- and C-termini of NF90 (show MMP4 Antibodies) participate in the heterodimerization with NF45 and that the formation of NF90 (show MMP4 Antibodies)-NF45 changes the conformation of NF90 (show MMP4 Antibodies)'s RNA-binding motifs to a status in which the co-operative interplay of the RNA-binding motifs is optimal.
NF90 (show MMP4 Antibodies)-NF45 stimulates an elevation of EGF receptor (show EGFR Antibodies) levels via the suppression of miR-7 (show LILRB1 Antibodies) biogenesis, resulting in the promotion of cell proliferation in Hepatocellular Carcinoma.
The results revealed that ILF2 is regulated by miR-7 (show LILRB1 Antibodies) and suggest that downregulation of miR-7 (show LILRB1 Antibodies) may be an important factor for the ILF2 overexpression in pancreatic carcinoma.
Deletion of the RNA binding domains of NF45 and NF90 (show MMP4 Antibodies) diminished the enhancement of HIV infection and gene expression.
NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.
Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis
The RNA binding complexes NF45-NF90 and NF45-NF110 associate dynamically with the c-fos gene and function as transcriptional coactivators.
NF45 and NF90 (show MMP4 Antibodies) are novel higher-eukaryote-specific factors required for the maturation of 60S ribosomal subunits.
These findings suggested that NF45 might play an important role in promoting the tumorigenesis of ESCC, and thus be a promising therapeutic target to prevent ESCC progression.
Data support a model in which NF45, NF90 (show MMP4 Antibodies), and NF110 (show MMP4 Antibodies) operate in feedback loops that enable them, through both overlapping and independent targets, to help balance the push and pull of pluripotency and differentiation cues.
NF90 (show MMP4 Antibodies)-NF45 complex induces centronuclear myopathy through increased dynamin 2 (show DNM2 Antibodies) expression by an NF90 (show MMP4 Antibodies)-NF45-induced reduction of miR (show MLXIP Antibodies)-133a expression in vivo.
Ilf2 is regulated during meiosis and associated to transcriptionally active chromatin
we propose that NF45 and NF90 (show MMP4 Antibodies) have the potential to activate SP-10 (show ACRV1 Antibodies) gene transcription, and that a chromatin modification event must occur first in order to provide access to these transcription factors.
The protein encoded by this gene is the 45 kDa component of nuclear factor of activated T-cells (NFAT), a heterodimer of 45 kDa and 90 kDa proteins. NFAT is a transcription factor required for T-cell expression of the interleukin 2 gene. It also binds RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. The complex has been shown to repair DNA breaks by nonhomologous end joining and can also negatively regulate the microRNA processing pathway. Alternative splicing results in multiple transcript variants. Related pseudogenes have been found on chromosomes 3 and 14.
interleukin enhancer binding factor 2, 45kDa
, interleukin enhancer-binding factor 2 homolog
, interleukin enhancer-binding factor 2-like
, interleukin enhancer binding factor 2, 45kD
, interleukin enhancer-binding factor 2
, nuclear factor of activated T-cells, 45-kDa
, nuclear factor of activated T-cells 45 kDa
, testis expressed gene 267
, liver regeneration-related protein LRRG031